These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 10637277)

  • 1. Critical role for CD8 in T cell receptor binding and activation by peptide/major histocompatibility complex multimers.
    Daniels MA; Jameson SC
    J Exp Med; 2000 Jan; 191(2):335-46. PubMed ID: 10637277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR.
    Denkberg G; Cohen CJ; Reiter Y
    J Immunol; 2001 Jul; 167(1):270-6. PubMed ID: 11418659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glu227-->Lys substitution in the acidic loop of major histocompatibility complex class I alpha 3 domain distinguishes low avidity CD8 coreceptor and avidity-enhanced CD8 accessory functions.
    Shen L; Potter TA; Kane KP
    J Exp Med; 1996 Nov; 184(5):1671-83. PubMed ID: 8920857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.
    Stone JD; Stern LJ
    J Immunol; 2006 Feb; 176(3):1498-505. PubMed ID: 16424178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between TCR affinity and necessity of coreceptor ligation: high-affinity peptide-MHC/TCR interaction overcomes lack of CD8 engagement.
    Kerry SE; Buslepp J; Cramer LA; Maile R; Hensley LL; Nielsen AI; Kavathas P; Vilen BJ; Collins EJ; Frelinger JA
    J Immunol; 2003 Nov; 171(9):4493-503. PubMed ID: 14568922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC.
    Hoerter JA; Brzostek J; Artyomov MN; Abel SM; Casas J; Rybakin V; Ampudia J; Lotz C; Connolly JM; Chakraborty AK; Gould KG; Gascoigne NR
    J Exp Med; 2013 Aug; 210(9):1807-21. PubMed ID: 23940257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation.
    Campanelli R; Palermo B; Garbelli S; Mantovani S; Lucchi P; Necker A; Lantelme E; Giachino C
    Int Immunol; 2002 Jan; 14(1):39-44. PubMed ID: 11751750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The MHC class II ligand lymphocyte activation gene-3 is co-distributed with CD8 and CD3-TCR molecules after their engagement by mAb or peptide-MHC class I complexes.
    Hannier S; Triebel F
    Int Immunol; 1999 Nov; 11(11):1745-52. PubMed ID: 10545478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite effects of endogenous peptide-MHC class I on T cell activity in the presence and absence of CD8.
    Stone JD; Aggen DH; Chervin AS; Narayanan S; Schmitt TM; Greenberg PD; Kranz DM
    J Immunol; 2011 May; 186(9):5193-200. PubMed ID: 21451107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8 binding to MHC class I molecules is influenced by T cell maturation and glycosylation.
    Daniels MA; Devine L; Miller JD; Moser JM; Lukacher AE; Altman JD; Kavathas P; Hogquist KA; Jameson SC
    Immunity; 2001 Dec; 15(6):1051-61. PubMed ID: 11754824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition surfaces of MHC class I.
    Jones EY; Tormo J; Reid SW; Stuart DI
    Immunol Rev; 1998 Jun; 163():121-8. PubMed ID: 9700505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8 coreceptor-mediated focusing can reorder the agonist hierarchy of peptide ligands recognized via the T cell receptor.
    Clement M; Knezevic L; Dockree T; McLaren JE; Ladell K; Miners KL; Llewellyn-Lacey S; Rubina A; Francis O; Cole DK; Sewell AK; Bridgeman JS; Price DA; van den Berg HA; Wooldridge L
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34272276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selecting T cell receptors with high affinity for self-MHC by decreasing the contribution of CD8.
    Sherman LA; Hesse SV; Irwin MJ; La Face D; Peterson P
    Science; 1992 Oct; 258(5083):815-8. PubMed ID: 1439792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term persistence of CD4(+) but rapid disappearance of CD8(+) T cells expressing an MHC class I-restricted TCR of nanomolar affinity.
    Engels B; Chervin AS; Sant AJ; Kranz DM; Schreiber H
    Mol Ther; 2012 Mar; 20(3):652-60. PubMed ID: 22233579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing the impact of CD8 antibodies on class I MHC multimer binding.
    Holman PO; Walsh ER; Jameson SC
    J Immunol; 2005 Apr; 174(7):3986-91. PubMed ID: 15778355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A low affinity TCR ligand restores positive selection of CD8+ T cells in vivo.
    Stefanski HE; Mayerova D; Jameson SC; Hogquist KA
    J Immunol; 2001 Jun; 166(11):6602-7. PubMed ID: 11359813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.
    Kao C; Daniels MA; Jameson SC
    Int Immunol; 2005 Dec; 17(12):1607-17. PubMed ID: 16263755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell activation and thymic tolerance induction require different adhesion intensities of the CD8 co-receptor.
    Knobloch M; Schönrich G; Schenkel J; Malissen M; Malissen B; Schmitt-Verhulst AM; Hämmerling GJ; Arnold B
    Int Immunol; 1992 Oct; 4(10):1169-74. PubMed ID: 1489732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-positive selection of thymocytes expressing a single TCR by multiple major histocompatibility complex molecules of both classes: implications for CD4+ versus CD8+ lineage commitment.
    Eshima K; Suzuki H; Shinohara N
    J Immunol; 2006 Feb; 176(3):1628-36. PubMed ID: 16424192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric beta2 microglobulin/CD3zeta polypeptides expressed in T cells convert MHC class I peptide ligands into T cell activation receptors: a potential tool for specific targeting of pathogenic CD8(+) T cells.
    Margalit A; Fishman S; Berko D; Engberg J; Gross G
    Int Immunol; 2003 Nov; 15(11):1379-87. PubMed ID: 14565936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.